Correlation Between Catalyst Pharmaceuticals and Gallant Venture

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Gallant Venture at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Gallant Venture into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Gallant Venture, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Gallant Venture and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Gallant Venture. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Gallant Venture.

Diversification Opportunities for Catalyst Pharmaceuticals and Gallant Venture

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Catalyst and Gallant is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Gallant Venture in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gallant Venture and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Gallant Venture. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gallant Venture has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Gallant Venture go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Gallant Venture

If you would invest  1,371  in Catalyst Pharmaceuticals on September 15, 2024 and sell it today you would earn a total of  767.00  from holding Catalyst Pharmaceuticals or generate 55.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Gallant Venture

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Gallant Venture 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gallant Venture has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Gallant Venture is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Catalyst Pharmaceuticals and Gallant Venture Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Gallant Venture

The main advantage of trading using opposite Catalyst Pharmaceuticals and Gallant Venture positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Gallant Venture can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gallant Venture will offset losses from the drop in Gallant Venture's long position.
The idea behind Catalyst Pharmaceuticals and Gallant Venture pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account